Refine by
Conductivity Analysis Articles & Analysis
34 news found
The EU Active Substance Master File (ASMF) is a technical document containing confidential information on an API that is submitted by the manufacturer of the API to the EMA or the medicines regulatory authority of an EU member state. As a form of DMF in the EU, the ASMF is used to support MAA or MAV by manufacturers of pharmaceutical preparations for human or veterinary use. The ASMF applies to ...
Specifically, Proregulations' ANDA services encompass the following areas: Compliance Consulting l Interpretation of relevant regulations and guidance l Analyzing the feasibility of ANDA for products in the U.S. l Developing a rational ANDA strategy Pre-submission activity management l DUNS/FEI application l ANDA numbering application l Preparation for pre-submission meeting with FDA Gap ...
A key distinguishing factor that sets Creative Enzymes apart in enzyme discovery is its state-of-the-art laboratories equipped with advanced technology. This enables the company to conduct comprehensive research and analysis for the efficient identification and characterization of novel enzymes. ...
We are delighted to welcome Roczen to the community of healthcare organisations leveraging Vantage Software! We look forward to working together and helping them deliver exceptional care and support to those living with chronic conditions. Book a Free Demo ...
CD Genomics' Degradome Sequencing service empowers researchers to conduct comprehensive analyses of RNA degradation patterns, providing an intricate portrait of the ever-evolving RNA landscape within cells and tissues. ...
Analytical Testing Services for Microspheres & MicroneedlesHaving abundant experience in the large-scale production of microspheres and microneedles, CD Formulation’s biopharmaceutical laboratory and amplification platform is also capable of conducting analytical testing services for customers worldwide to ensure the quality of microspheres and microneedles. ...
Alfa Chemistry, a leading pharmaceutical supplier, has recently announced the addition of three new APIs to its full-ranged product catalog, i.e., tofacitinib citrate, tamoxifen citrate, and epalrestat. These new products are introduced to meet the growing demands of the pharmaceutical market. Tofacitinib Citrate Tofacitinib Citrate is a medication used to treat rheumatoid arthritis, psoriatic ...
KCAS Bioanalytical & Biomarker Services is conducting the pharmacokinetic (PK) analysis. “As Cingulate proceeds with its mission to bring next-generation medications to patients where standard-of-care treatments result in suboptimal outcomes, we are pleased to have completed this trial advancing our understanding of the absorption and bioavailability ...
Creative Biogene provides comprehensive mitochondrial gene expression solutions, which aim to conduct in-depth analyses of mitochondrial disorders from a holistic perspective. ...
Additionally, revenue growth was driven by United States Department of Defense (DoD) orders as well as third-party companies contracting with Daxor to conduct blood volume analysis on their products. The Company also reported its successful execution of a Department of Defense contract to build a next-generation portable rapid blood volume analyzer for both ...
Together with state-of-the-art analytical instruments, the company is capable of conducting analytical process development and validation services for drug formulation projects. ...
Oral and poster presentations highlight robust and high-quality immune responses following administration of novel arenaviral therapeutic vaccines in preclinical setting Alternating 2-vector therapy induces greater immune response than single-vector therapy in preclinical setting and translates into significant reduction of viral load HOOKIPA Pharma Inc. (NASDAQ: HOOK, ...
(NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced the publication of a scientific paper titled “Exodus: Sequencing-based Pipeline for Quantification of Pooled Variants” in the journal, Bioinformatics. The research ...
ByBiomX
Post hoc analyses conducted in patient populations at greater risk of progression to severe disease or death suggests that SNG001 may have an important clinical effect on top of standard of care Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, today ...
“FFRangio has been in use in our cath lab since 2016 and we have taken part in several studies demonstrating its excellent diagnostic performance compared to the gold standard wire-based FFR, culminating in the pivotal FAST-FFR trial and our leading role in conducting a pooled analysis that compared FFRangio to wire-based FFR. Based on the results of these ...
Efficacy A total of 623 patients were randomised to receive SNG001 (n=309) or placebo (n=314) in addition to standard of care (SOC). The primary analysis was conducted in the intention-to-treat population (ITT; all randomised patients). ...
--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its iDose® TR sustained-release travoprost implant continued to provide sustained substantial reductions in intraocular pressure (IOP) in a 36-month ...
For artificially designed protein drugs with specific biological activities and curative effects, such as engineered antibodies, antibody-drug conjugates, antibody-based fusion proteins, etc., it is necessary to conduct careful analysis and testing of factors such as modification or processing efficiency, modification specificity and accuracy, and stability after ...
BioGX’s SARS-CoV-2 surveillance program includes exhaustive in-silico analysis and experimental testing by BioGX scientists using RNA sequences containing the mutations present within the emerging SARS-CoV-2 variants. The analysis conducted by BioGX confirmed the BioGX portfolio of COVID-19 tests maintain detection coverage for all variants ...
Bioinformatics-analysis Platform belongs to CD Genomics, which provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis business. ...